DK1194415T3 - Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling - Google Patents

Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling

Info

Publication number
DK1194415T3
DK1194415T3 DK00944119T DK00944119T DK1194415T3 DK 1194415 T3 DK1194415 T3 DK 1194415T3 DK 00944119 T DK00944119 T DK 00944119T DK 00944119 T DK00944119 T DK 00944119T DK 1194415 T3 DK1194415 T3 DK 1194415T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
preparation
new
piperazinylalkylthiopyrimidine
Prior art date
Application number
DK00944119T
Other languages
Danish (da)
English (en)
Inventor
Karoly Tihanyi
Andras Egyed
Simonek Ildiko Ratzne
Daniel Bozsing
Gabor Nemeth
Gyula Simig
Laszlo Poszavacz
Ivan Jakoczi
Gyoergy Levay
Istvan Gacsalyi
Janos Wellman
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9902214A external-priority patent/HU9902214D0/hu
Priority claimed from HU0002156A external-priority patent/HU227402B1/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of DK1194415T3 publication Critical patent/DK1194415T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00944119T 1999-06-29 2000-06-29 Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling DK1194415T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9902214A HU9902214D0 (en) 1999-06-29 1999-06-29 Novel piperazinyl-alkyl-thio-pyrimidine-derivatives, process for producing them and medicaments containing the same
HU0002156A HU227402B1 (en) 2000-06-06 2000-06-06 Novel piperazinyl alkylthio pyrimidinyl derivatives, pharmaceutical compositions containing such active ingredients and process for producing the active ingredients
PCT/HU2000/000064 WO2001000617A2 (en) 1999-06-29 2000-06-29 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same

Publications (1)

Publication Number Publication Date
DK1194415T3 true DK1194415T3 (da) 2003-12-08

Family

ID=89998587

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00944119T DK1194415T3 (da) 1999-06-29 2000-06-29 Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling

Country Status (19)

Country Link
US (1) US6469168B1 (zh)
EP (1) EP1194415B1 (zh)
JP (1) JP2003503404A (zh)
KR (1) KR20020016872A (zh)
CN (1) CN1173956C (zh)
AT (1) ATE247645T1 (zh)
AU (1) AU5835400A (zh)
CA (1) CA2376307A1 (zh)
CZ (1) CZ20014575A3 (zh)
DE (1) DE60004671T2 (zh)
DK (1) DK1194415T3 (zh)
ES (1) ES2204643T3 (zh)
HK (1) HK1046902A1 (zh)
HR (1) HRP20010969B1 (zh)
PL (1) PL352476A1 (zh)
PT (1) PT1194415E (zh)
RU (1) RU2245334C2 (zh)
SK (1) SK285670B6 (zh)
WO (1) WO2001000617A2 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1665506A (zh) 2002-07-02 2005-09-07 霍夫曼-拉罗奇有限公司 作为ccr－3受体拮抗剂ⅸ的2,5－取代的嘧啶衍生物
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
US11351168B1 (en) 2008-06-27 2022-06-07 Celgene Car Llc 2,4-disubstituted pyrimidines useful as kinase inhibitors
JP2011526299A (ja) 2008-06-27 2011-10-06 アビラ セラピューティクス， インコーポレイテッド ヘテロアリール化合物およびそれらの使用
AU2011289604C1 (en) * 2010-08-10 2016-04-21 Celgene Avilomics Research, Inc. Besylate salt of a BTK inhibitor
NZ609957A (en) 2010-11-01 2015-08-28 Celgene Avilomics Res Inc Heterocyclic compounds and uses thereof
EP2635285B1 (en) 2010-11-01 2017-05-03 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
WO2012064706A1 (en) 2010-11-10 2012-05-18 Avila Therapeutics, Inc. Mutant-selective egfr inhibitors and uses thereof
AR088570A1 (es) 2011-10-28 2014-06-18 Celgene Avilomics Res Inc Metodos para tratar una enfermedad o trastorno relacionado con la tirosina quinasa de bruton
BR112014022789B1 (pt) 2012-03-15 2022-04-19 Celgene Car Llc Formas sólidas de um inibidor de quinase de receptor do fator de crescimento epidérmico, composição farmacêutica e usos do mesmo
SG11201405692UA (en) 2012-03-15 2014-10-30 Celgene Avilomics Res Inc Salts of an epidermal growth factor receptor kinase inhibitor
EP2935226A4 (en) 2012-12-21 2016-11-02 Celgene Avilomics Res Inc HETEROARYL COMPOUNDS AND USES THEREOF
MX2015009952A (es) 2013-02-08 2015-10-05 Celgene Avilomics Res Inc Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos.
US9492471B2 (en) 2013-08-27 2016-11-15 Celgene Avilomics Research, Inc. Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
US9415049B2 (en) 2013-12-20 2016-08-16 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
DK3179858T3 (da) 2014-08-13 2019-07-22 Celgene Car Llc Forme og sammensætninger af en ERK-inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76266A (en) * 1995-10-31 1997-07-28 Egyt Gyogyszervegyeszeti Gyar New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components

Also Published As

Publication number Publication date
HRP20010969B1 (en) 2005-04-30
CN1359375A (zh) 2002-07-17
JP2003503404A (ja) 2003-01-28
HRP20010969A2 (en) 2003-04-30
DE60004671T2 (de) 2004-07-29
KR20020016872A (ko) 2002-03-06
ATE247645T1 (de) 2003-09-15
WO2001000617A3 (en) 2001-03-01
SK19272001A3 (sk) 2002-05-09
WO2001000617A2 (en) 2001-01-04
SK285670B6 (sk) 2007-06-07
EP1194415B1 (en) 2003-08-20
RU2245334C2 (ru) 2005-01-27
PL352476A1 (en) 2003-08-25
DE60004671D1 (de) 2003-09-25
CZ20014575A3 (cs) 2002-04-17
HK1046902A1 (zh) 2003-01-30
CN1173956C (zh) 2004-11-03
ES2204643T3 (es) 2004-05-01
AU5835400A (en) 2001-01-31
PT1194415E (pt) 2004-01-30
CA2376307A1 (en) 2001-01-04
US6469168B1 (en) 2002-10-22
EP1194415A2 (en) 2002-04-10

Similar Documents

Publication Publication Date Title
MXPA04007470A (es) Piridinonas sustituidas.
DK1194415T3 (da) Nye piperazinylalkylthiopyrimidinderivater, farmaceutiske sammensætninger indeholdende disse samt en fremgangsmåde til deres fremstilling
NO972910L (no) Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
NO20055092L (no) Substituerte pyrimidioner
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
WO2005018557A3 (en) Substituted pyridinones
NO20055219L (no) Nye forbindelser
NO20062139L (no) Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
GEP20022678B (en) Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors, their Pharmaceutical compositions and methods for Treatment
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
FI963294A0 (fi) Naftyyliamidit keskushermostoaineina
EE03253B1 (et) (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised
NO20055977L (no) Nye benzimidazolderivater
NO20021859L (no) Nye oligosakkarider, deres fremstilling samt farmasöytiske preparater inneholdende oligosakkaridene
NO20045486L (no) Nye forbindelser og deres anvendelse
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
NO20020282D0 (no) Nytt difenylpiperidinderivat
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
DE60121431D1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
FI905957A (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central